Pharma - Industry – Focus

 

Custom Search

Biocon opens new R&D facility at its Biocon Park


Syngene International, a subsidiary of Biocon has opened  a new R&D facility for its client Bristol Myers Squibb. This unit built on 200000 sq.feet has currently 270 researchers and has plans to increase it to 360 by year end and will carry out drug discovery and development from initial hit to optimisation to clinical studies. 

Custom Search

Copyright © 2013 Ibis Research Information Services Pvt Ltd. All Rights Reserved.
Contact : Ibis Research Information Services Pvt Ltd., 28, Rajaji Street, NGO Colony
Guduvancherry, Chennai -603 202   Mobile : 0-97898-37940 email : ibischennai@gmail.com Privacy Policy